As pharmaceutical manipulation of GSH concen-trations is an intervention likely to increase within the coming years, health clinicians need to be aware of the rationale of such attempts and methods of administering bioavailable forms of GSH or its substrates.
Examples include diabetes, lung diseases, blood clots, body inflammations, autoimmune diseases, electrolyte disorders, and cardiovascular diseases
The result is a white, amorphous, lyophilized powder which is freely soluble in sterile water or diluted acetic acid to produce a clear and colorless solution
Thus, there is a strong argument that boosting NAD + levels may combat all subclasses of human PE (8), thus making it a very promising therapeutic intervention
-29% Sale
Do me a favor and try it yourself